Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium polystyrene sulfonate for interdialytic hyperkalemia in maintenance hemodialysis
ChiCTR-TTRCC-14004155Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jan 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calcium polystyrene sulfonate in hyperkalemia (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Potassium. Started Jan 2014; status: completed.
02
Drugs
calcium polystyrene sulfonate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on ChiCTR-TTRCC-14004155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-14004155.